Literature DB >> 30687630

Evolution of radiotherapy techniques in breast conservation treatment.

John Boyages1,2, Lesley Baker2.   

Abstract

Radiation therapy (RT) is an important component of breast cancer treatment that reduces local recurrence and improves survival after breast conservation. Breast conservation rates have increased significantly since the late 1980s and techniques have improved with greater awareness of the impact of radiation on the heart. An overview of randomized controlled trials of breast conservation using standard whole breast irradiation, whole breast hypofractionation, accelerated partial breast irradiation (APBI) and intraoperative radiation are reviewed. Selection criteria for breast conservation and the utility of adding a boost dose to the primary tumor site are reviewed. Modern dose constraints are documented and 10 different radiation techniques from the 1980s through to modern volumetric modulated arc therapy (VMAT) are compared for a patient where the breast and internal mammary nodes are treated. A radiation boost reduces the risk of a recurrence for most, but not all patients. Short courses of RT over 3-4 weeks are generally as effective as longer courses. Short-term follow-up of trials of APBI show promise for selected good prognosis subgroups. The role of intraoperative radiation remains controversial. In the last 30 years, there have been significant advances in radiation techniques. Modern radiotherapy equipment and techniques will reduce complications and improve survival rates.

Entities:  

Keywords:  Breast neoplasms; mastectomy, segmental; neoplasm recurrence, local; radiotherapy, survival

Year:  2018        PMID: 30687630      PMCID: PMC6323255          DOI: 10.21037/gs.2018.11.10

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  95 in total

1.  Radiation therapy after breast-conserving surgery; first results of a randomised clinical trial in patients with low risk of recurrence.

Authors:  K-J Winzer; R Sauer; W Sauerbrei; E Schneller; W Jaeger; M Braun; J Dunst; T Liersch; M Zedelius; K Brunnert; H Guski; C Schmoor; M Schumacher
Journal:  Eur J Cancer       Date:  2004-05       Impact factor: 9.162

2.  Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial.

Authors:  J A van Dongen; A C Voogd; I S Fentiman; C Legrand; R J Sylvester; D Tong; E van der Schueren; P A Helle; K van Zijl; H Bartelink
Journal:  J Natl Cancer Inst       Date:  2000-07-19       Impact factor: 13.506

3.  Pulmonary complications following different radiotherapy techniques for breast cancer, and the association to irradiated lung volume and dose.

Authors:  P A Lind; B Wennberg; G Gagliardi; T Fornander
Journal:  Breast Cancer Res Treat       Date:  2001-08       Impact factor: 4.872

4.  Predictors of Mastectomy for Women with Breast Cancer in the Greater Western Region of Sydney.

Authors:  Richard Taylor; Joanne M. Stubbs; Allan O. Langlands; John Boyages
Journal:  Breast J       Date:  1999-03       Impact factor: 2.431

5.  Breast conservation: long-term Australian data.

Authors:  J Boyages; C Bosch; A O Langlands; A M Bilous; B Barraclough; V J Gebski
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

6.  Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.

Authors:  Carson Leong; John Boyages; Upali W Jayasinghe; Michael Bilous; Owen Ung; Boon Chua; Elizabeth Salisbury; Angela Y Wong
Journal:  Cancer       Date:  2004-05-01       Impact factor: 6.860

7.  Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial.

Authors:  Matthew M Poggi; David N Danforth; Linda C Sciuto; Sharon L Smith; Seth M Steinberg; David J Liewehr; Cynthia Menard; Marc E Lippman; Allen S Lichter; Rosemary M Altemus
Journal:  Cancer       Date:  2003-08-15       Impact factor: 6.860

8.  Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer.

Authors:  Anthony W Fyles; David R McCready; Lee A Manchul; Maureen E Trudeau; Patricia Merante; Melania Pintilie; Lorna M Weir; Ivo A Olivotto
Journal:  N Engl J Med       Date:  2004-09-02       Impact factor: 91.245

9.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

Authors:  Bernard Fisher; Stewart Anderson; John Bryant; Richard G Margolese; Melvin Deutsch; Edwin R Fisher; Jong-Hyeon Jeong; Norman Wolmark
Journal:  N Engl J Med       Date:  2002-10-17       Impact factor: 91.245

10.  Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer.

Authors:  Umberto Veronesi; Natale Cascinelli; Luigi Mariani; Marco Greco; Roberto Saccozzi; Alberto Luini; Marisel Aguilar; Ettore Marubini
Journal:  N Engl J Med       Date:  2002-10-17       Impact factor: 91.245

View more
  4 in total

1.  Risk factors and specific cancer types of second primary malignancies in patients with breast cancer receiving adjuvant radiotherapy: a case-control cohort study based on the SEER database.

Authors:  Chuanxin Xia; Lei Qin; Yinzhi Wang; Ling Yao; Benchang Shia; Szu-Yuan Wu
Journal:  Am J Cancer Res       Date:  2022-06-15       Impact factor: 5.942

2.  Knowledge-Based Volumetric Modulated Arc Therapy Treatment Planning for Breast Cancer.

Authors:  Oscar Abel Apaza Blanco; María José Almada; Albin Ariel Garcia Andino; Silvia Zunino; Daniel Venencia
Journal:  J Med Phys       Date:  2021-12-02

3.  The study of sirtuins in breast cancer patients before and after radiotherapy

Authors:  Nazlı Helvacı; Hatice Saraçoğlu; Oğuz Galip Yıldız; Eser Kılıç
Journal:  Turk J Med Sci       Date:  2021-06-28       Impact factor: 0.973

Review 4.  The use of moderately hypofractionated post-operative radiation therapy for breast cancer in clinical practice: A critical review.

Authors:  Gustavo Nader Marta; Charlotte Coles; Orit Kaidar-Person; Icro Meattini; Tarek Hijal; Yvonne Zissiadis; Jean-Philippe Pignol; Duvern Ramiah; Alice Y Ho; Skye Hung-Chun Cheng; Gemma Sancho; Birgitte Vrou Offersen; Philip Poortmans
Journal:  Crit Rev Oncol Hematol       Date:  2020-08-26       Impact factor: 6.312

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.